Comparison of the Efficacy of Ticagrelor Combined With ASA to ASA Alone in Patients With Stroke

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 13000 participants.

Also called NCT04962451

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; double masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 13,000 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT04962451
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
China (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT04962451. Randomized; double masking; primary purpose treatment. Start 2017-09-01 (actual); primary completion 2019-09-30 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Comparison of the Efficacy of Ticagrelor Combined With ASA to ASA Alone in Patients With Stroke
Condition
Cerebrovascular Accident
Condition
Cerebrovascular Accident, Acute
Intervention (Drug)
ticagrelor + ASA
Intervention (Drug)
Placebo+ASA
Lead sponsor
Peking University Third Hospital (class: other)
Collaborator
AstraZeneca (class: industry)

Record details

Record id
cardio:ct-nct04962451
Content hash
51a22ea67b74f22cd2715192357731f6a04688a6e86603a63b99c1762dc1e5b9